PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
14-Dec-2023 Vandria Announces $20.6M (CHF18M) Series A Financing Led by ND Capital to Drive CNS Clinical Program and Mitochondrial Therapeutics Platform Vandria
14-Dec-2023 Applied DNA Announces Joint Development Agreement to Integrate Linea(TM) IVT Platform into CDMO Kudo Biotechnology’s mRNA Manufacturing Workflow AccessWire
14-Dec-2023 Nerviano Medical Sciences and Italfarmaco Announce Licensing of Linker-Payload Technology to Develop and Commercialize a Novel Peptide-Drug Conjugate Businesswire
14-Dec-2023 Oasis Cannabis Dispensaries' 8-Year Anniversary: A Celebration of Success, Growth, and Employee Dedication AccessWire
14-Dec-2023 Mission Therapeutics announces US FDA approval to initiate Phase II clinical trial of its lead asset MTX652 in Acute Kidney Injury Mission Therapeutics
14-Dec-2023 Colonoscope Market: Future Prospects and Developments | CAGR 7.6 The Wire Times
14-Dec-2023 Vertebroplasty and Kyphoplasty Market: Innovations and Future Outlook 2031 | CAGR 5.6% The Wire Times
14-Dec-2023 Lindus Health and Thirty Madison complete enrolment of personalised dermatology care pilot study Lindus Health
14-Dec-2023 Levicept Completes Recruitment in Phase II Clinical Trial of Neurotrophin Modulator, LEVI-04 Levicept
14-Dec-2023 CellProthera advances towards its Phase III clinical trials with the development of a new potency assay CellProthera
14-Dec-2023 Nottingham CRO Platelet Services marks fifth anniversary Platelet Services
14-Dec-2023 U.S. IVD Market to Record an Exponential CAGR by 2032 – Exclusive Report by Allied Market Research The Wire Times
14-Dec-2023 IBSA and Her Skipper Alberto Bona Win the 2023 Class40 Championship Businesswire
14-Dec-2023 Biocomposites exceeds revenue expectations and takes a big step forward in its research and development Biocomposites
14-Dec-2023 Engimmune Therapeutics strikes ‘fast-forward’ micro-fluidics collaboration with Swiss innovator CSEM Engimmune Therapeutics
14-Dec-2023 SiSaf Announces Completion of Patient Enrolment in Phase II Trial of Bio-Courier® Drug Formulation for the Treatment of Mild/Moderate Alopecia Areata SiSaf
14-Dec-2023 MitoRx Therapeutics Announces Close of Seed Extension Financing Round to Advance its Mitochondrial-Protective Therapeutics to Treat Degenerative Diseases MitoRx Therapeutics
14-Dec-2023 HUTCHMED Announces that it has Completed Enrollment of a Phase II/III Trial of Fruquintinib in Combination with Sintilimab for Advanced Renal Cell Carcinoma in China HUTCHMED
14-Dec-2023 DARZALEX® (daratumumab) Subcutaneous Formulation-Based Quadruplet Therapy Regimen Shows Significant Improvement in Outcomes for Patients with Transplant-Eligible Newly Diagnosed Multiple Myeloma Janssen
14-Dec-2023 CellCentric discloses significant new clinical data, demonstrating inobrodib’s efficacy in ongoing Phase I/IIa clinical trials CellCentric